Intact aggrecan and fragments generated by both aggrecanse and metalloproteinase-like activities are present in the developing and adult rat spinal cord and their relative abundance is altered by injury

Journal of Neuroscience

Volumn 21, Issue 13, 2001, Pages 4772-4781

  Lemons, Michele L ^a,b   Sandy, John D ^c   Anderson, Douglas K ^a,b,d   Howland, Dena R ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d Malcom Randal Medical Center   (United States)

Author keywords

Aggrecan; Aggrecanase; Aggregating proteoglycan; Brevican; Chondroitin sulfate proteoglycan; Development; Metalloproteinase; Neurocan; Spinal cord; Spinal cord injury

Indexed keywords

AGGRECAN; BREVICAN; CHONDROITIN SULFATE; DISINTEGRIN; METALLOPROTEINASE; NEUROCAN; PROTEOGLYCAN; THROMBOSPONDIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CARTILAGE; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SPINAL CORD HEMISECTION; SPINAL CORD INJURY; WESTERN BLOTTING;

EID: 0035400082     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-13-04772.2001     Document Type: Article

References (81)

1. Binding of two growth factor families to separate domains of the proteoglycan betaglycan
2. Generation and characterization of aggrecanase
3. On the existence of a cartilage-like proteoglycan and link proteins in the central nervous system
4. Transforming growth factor-beta receptors and binding proteoglycans
5. Chondroitin sulfate as a regulator of neuronal patterning in the retina
6. Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: An overview
7. Regeneration of adult axons in white matter tracts of the central nervous system
8. Complete primary structure of the rat cartilage proteoglycan core protein deduced from cDNA clones
9. Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan
10. Inhibition of neurite growth by the NG2 chondroitin sulfate proteoglycan
11. Chondroitin sulfate proteoglycans in the developing central nervous system. I. Cellular sites of synthesis of neurocan and phosphacan
12. Involvement of a chondroitin sulfate proteoglycan in the avoidance of chick epidermis by dorsal root ganglia fibers: A study using beta-D-xyloside
13. Activated macrophages and the blood-brain barrier: Inflammation after CNS injury leads to increases in putative inhibitory molecules
14. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage
15. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B
16. Degradation of cartilage aggrecan by collagenase-3 (MMP-13)
17. The high molecular weight Cat-301 chondroitin sulfate proteoglycan from brain is related to the large aggregating proteoglycan from cartilage, aggrecan
18. Chondroitin sulfate proteoglycan and tenascin in the wounded adult mouse neostriatum in vitro: Dopamine neuron attachment and process outgrowth
19. Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture
20. Functions of brain chondroitin sulfate proteoglycans during developments: Interactions with adhesion molecules
21. Isolation and characterization of proteoglycans
22. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta
23. Monoclonal antibodies that specifically recognize neopeptide sequences generated by "aggrecanase" and matrix metalloproteinase cleavage of aggrecan; application to catabolism in situ and in vitro
24. Large diameter primary afferent input is required for expression of the CAT-301 proteoglycan on the surface of motor neurons
25. Two types of brain chondroitin sulfate proteoglycan: Their distribution and possible functions in the rat embryo
26. Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis
27. Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene
28. Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth
29. Aggrecan degradation in osteoarthritis and rheumatoid arthritis
30. Cell-mediated catabolism of aggrecan. Evidence that cleavage at the "aggrecanase" site (Glu373-Ala374) is a primary event in proteolysis of the interglobular domain
31. Quantification of matrix metalloproteinase-generated aggrecan G1 fragment using monospecific anti-peptide serum
32. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints
33. Chondroitin sulfate proteoglycan immunoreactivity increases following spinal cord injury and transplantation
34. S103L reactive chondroitin sulfate proteoglycan (aggrecan) mRNA expressed in developing chick brain and cartilage is encoded by a single gene
35. Brain-enriched hyaluronan binding (BEHAB)/Brevican cleavage in a glioma cell line is mediated by a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family member
36. Chondroitin sulfate and chondroitin/keratan sulfate proteoglycans of nervous tissue: Developmental changes of neurocan and phosphacan
37. Chondroitin sulfate proteoglycans in the developing central nervous system. II. Immunocytochemical localization of neurocan and phosphacan
38. High affinity binding and overlapping localization of neurocan and phosphacan/protein-tyrosine phosphatase-zeta/beta with tenascin-R, amphoterin, and the heparin-binding growth-associated molecule
39. Differential regulation of expression of hyaluronan-binding proteoglycans in developing brain: Aggrecan, versican, neurocan, and brevican
40. Cathespin B: An alternative protease for the generation of an aggrecan "metalloproteinase" cleavage neoepitope
41. Peanut agglutination and chondroitin-6-sulfate are molecular markers for tissues that act as barriers to axon advance in the avian embryo
42. Glycoconjugates mark a transient barrier to neural crest migration in the chicken embryo
43. Distribution of keratin sulphate and chondroitin sulphate in wild type and white mutant axolotl embryos during neural crest cell migration
44. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states
45. Spatial and temporal changes in the distribution of proteoglycans during avian neural crest development
46. Absence of neural crest cells from the region surrounding implanted notochords in situ
47. Age-dependent inhibition of neural crest migration by the notochord correlates with alterations in the S103L chondroitin sulfate proteoglycan
48. Glycosaminoglycan sulfation in human osteoarthritis. Disease-related alterations at the non-reducing termini of chondroitin and dermatan sulfate
49. Isolation and characterization of developmentally-regulated chondroitin sulfate and chondroitin/keratan sulfate proteoglycans of brain identified with monoclonal antibodies
50. Cloning and primary structure of neurocan, a developmentally regulated, aggregating chondroitin sulfate proteoglycan of brain
51. Mapping of a defined neurocan binding site to distinct domains of tenascin-C
52. Regrowth of motor axons following spinal cord lesions: Distribution of laminin and collagen in the CNS scar tissue
53. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: Inhibition of matrix metalloproteinase-9 reduces infarct size
54. Matrix metalloproteinases in brain injury
55. Heparan sulfate: A piece of information
56. Proteolytic degradation of normal and osteoarthritic cartilage matrix
57. Western analysis of aggrecan in normal, acutely injured and late stage osteoarthritic human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for functional destruction of aggrecan whereas MMP-like activity is responsible for non-destructive aggrecan cleavage
58. Analysis of the catabolism of aggrecan in cartilage explants by quantitation of peptides from the three globular domains
59. The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain
60. Pathways of aggrecan processing in joint tissues. Implications for disease mechanism and monitoring
61. Chondrocyte-mediated catabolism of aggrecan: Aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine
62. The intermediates of aggrecanase-dependent cleavage of aggrecan in rat chondrosarcoma cells treated with interleukin-1
63. Versican V1 proteolysis in human aorta in vivo occurs at the Glu 441-Ala 442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4
64. Developmental expression of S103L cross-reacting proteoglycans in embryonic chick
65. Brain aggrecan
66. Domain organization, genomic structure, evolution, and regulation of expression of the aggrecan gene family
67. Transcripts for secreted and GPI-anchored brevican are differentially distributed in rat brain
68. Neurite outgrowth on a step gradient of chondroitin sulfate proteoglycan (CS-PG)
69. Sulfated proteoglycans in astrologlial barriers inhibit neurite outgrowth in vitro
70. A chondroitin sulfate proteoglycan may influence the direction of retinal ganglion cell outgrowth
71. Growth cone behavior in the presence of soluble chondroitin sulfate proteoglycan (CSPG), compared to behavior on CSPG bound to laminin or fibronectin
72. Boundaries during normal and abnormal brain development: In vivo and in vitro studies of glia and glycoconjugates
73. Aggrecan degradation in human intervertebral disc and articular cartilage
74. Purification and cloning of aggrecanase-1: A member of the ADAMTS family of proteins
75. Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4)
76. Chondroitin sulfate proteoglycan expression pattern in hippocampal development: Potential regulation of axon tract formation
77. cDNA cloning and the identification of an aggrecanase-like cleavage site in rat brevican
78. The brain chondroitin sulfate proteoglycan brevican associates with astrocytes ensheathing cerebellar glomeruli and inhibits neurite outgrowth from granule neurons
79. Brevican: A major proteoglycan in adult brain
80. Lecticans: Organizers of the brain extracellular matrix
81. Characterization of an activity-dependent, neuronal surface proteoglycan identified with monoclonal antibody Cat-301